Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
ZetaRx Biosciences
AddedMar 20, 2024
UpdatedJun 18, 2026
ZetaRx Biosciences

ZetaRx Biosciences

Seed

Seattle-based medical organization specializing in healthcare sector since 2009.

HQ
Seattle, WA, US
Founded
2009
Overview
Compare
Fundraising
Employees

ZetaRx Biosciences, founded in 2009 and based in Seattle, Washington, operates in the healthcare sector. The company focuses on developing innovative medical solutions to address critical health issues. Their mission is to advance healthcare through cutting-edge research and technology.

ZetaRx Biosciences has made significant strides in the medical field, contributing to advancements in healthcare. Their work has had a notable impact on patient care and treatment options, positioning them as a key player in the industry.

ZetaRx Biosciences - Similar Companies

ZZ Biotech logo

ZZ Biotech

zzbiotech.com

Rjs Biologics logo

Rjs Biologics

Zetagen Therapeutics logo

Zetagen Therapeutics

zetagen.com

Prosetta logo

Prosetta

prosetta.com

X-Biotix Therapeutics logo

X-Biotix Therapeutics

Oxeia Biopharmaceuticals logo

Oxeia Biopharmaceuticals

oxeiabiopharma.com

Zurex Pharma logo

Zurex Pharma

zurexpharma.com

Biopsych Health Systems logo

Biopsych Health Systems

RS BioTherapeutics logo

RS BioTherapeutics

Ibex Biosciences logo

Ibex Biosciences

ibex.bio

Ziran Biopharmaceutical logo

Ziran Biopharmaceutical

Biotheryx logo

Biotheryx

biotheryx.com

Zena Therapeutics logo

Zena Therapeutics

CNine Biosolutions logo

CNine Biosolutions

Transgenrx logo

Transgenrx

ZetaRx Biosciences - Quick Facts

Who are ZetaRx Biosciences' competitors?

Companies similar to ZetaRx Biosciences include ZZ Biotech, Rjs Biologics, Zetagen Therapeutics and Prosetta.

When was ZetaRx Biosciences founded?

ZetaRx Biosciences was founded in 2009.

Where is ZetaRx Biosciences' headquarters located?

ZetaRx Biosciences' headquarters is located in Seattle, WA, US.

When was ZetaRx Biosciences' last funding round?

ZetaRx Biosciences' most recent funding round was for $2M (USD) in December 2012.

How much has ZetaRx Biosciences raised to-date?

As of Dec 12, 2012, ZetaRx Biosciences has raised a total of $2.8M (USD).

How many employees does ZetaRx Biosciences have?

ZetaRx Biosciences has 5 employees as of Feb 5, 2024.

ZetaRx Biosciences - Classification

Ownership
  • Private
Technology
  • Biotech
  • HealthTech
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Medical
Tags
  • Software
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 4 more industry codes
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified